Washington [US], March 1 (ANI): US' Centers for Disease Control and Prevention (CDC) advisory committee on Sunday has voted to recommend that Johnson & Johnson's COVID-19 vaccine can be given to people ages 18 and older in the United States.
Trader Joe s employee called for stronger coronavirus measures, then got fired
Brittany Shammas and Hannah Knowles, The Washington Post
Feb. 28, 2021
FacebookTwitterEmail
The Trader Joe s employee appealed directly to the CEO.
In a letter citing a medical journal and experts who study respiratory transmission of the coronavirus, Ben Bonnema called on the grocery chain s head, Dan Bane, to adopt more-stringent safety protocols. Among his requests: improving filtration, requiring masks without exception and adopting a three-strikes policy for removing uncooperative customers from stores. We put our lives on the line everyday by showing up to work, wrote Bonnema, who is a crew member at a New York location. Please, show up for us by adopting these policies.
According to the Franny Strong Foundation, the Centers for Disease Control and Prevention (CDC) voted to approve the Johnson & Johnson COVID-19 vaccine for human use in the United States.
J&J s COVID-19 vaccine could protect millions - if people take it
One-dose version s overall efficacy is below Pfizer, Moderna
Angelica LaVito and Riley Griffin, Bloomberg
March 1, 2021
FacebookTwitterEmail
Johnson & Johnson’s Covid-19 vaccine could protect millions more Americans from contracting the coronavirus. The key will be assuring people that the single-shot vaccine is worth taking, as its overall efficacy appears lower than the two-dose ones already on the market in the U.S.
J&J’s shot, which U.S. regulators authorized Saturday, is more convenient than the vaccines cleared by the Food and Drug Administration last year. It requires one injection and can be stored for months in a refrigerator. State health officials and the Biden administration see it as a way to quickly host mass clinics as more transmissible virus variants continue to spread. Yet the ease of distributing the vaccine will need to be balanced with the risk of creating the perception that J&J’s sho